Stämm Biotech
Latest round
- Series A
Last raised
- Jan 2022
Total raised
- $17M
Investors
- 11
About Stämm Biotech
Founded in 2014 in Buenos Aires, Argentina, Stämm Biotech focuses on biomanufacturing for biologics and cell therapies. The founders, Federico Vegh and Yuyo Vegh, have experience in launching innovative biotech solutions.Stämm specializes in advanced biomanufacturing solutions tailored for the production of biologics and cell therapies. The company's core offerings include automated and continuous manufacturing systems that enhance the efficiency and scalability of biologics production, as well as comprehensive support for cell line development aimed at both clinical and commercial manufacturing. Stämm employs AI generative models to create cell-predictive pipelines, leveraging multi-omics biological data to optimize the biomanufacturing process.Stämm generates revenue through structured partnerships and collaborations with clients primarily in the biopharmaceutical sector. The company's business model involves B2B transactions where clients engage in co-development opportunities for advanced biomanufacturing solutions, including project-based contracts with upfront payments for technology implementation and performance-based milestones. The company aims to deepen its international presence, targeting new markets in North America and Europe by 2024, with a focus on launching upcoming products designed to meet the evolving needs of the biotechnology sector.
Who invested in Stämm Biotech
11 investors across 4 rounds
See all investors in Stämm Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Stämm Biotech
Who invested in Stämm Biotech?
Stämm Biotech has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Stämm Biotech raised?
Stämm Biotech has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Stämm Biotech last raise money?
Stämm Biotech's most recent round on record is a Series A, in Jan 2022.
What does Stämm Biotech do?
Founded in 2014 in Buenos Aires, Argentina, Stämm Biotech focuses on biomanufacturing for biologics and cell therapies.
Where is Stämm Biotech headquartered?
Stämm Biotech is headquartered in Buenos Aires, Argentina.
Which VCs invest in companies like Stämm Biotech?
Among active investors with capital left to deploy, Crescera Capital, Kaszek Ventures, dao5 and LIV Capital back biotechnology companies at Stämm Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Stämm Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.